Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
Ticker SymbolHNGE
Company nameHinge Health Inc
IPO dateMay 22, 2025
Founded at2016
CEOMr. Daniel (Dan) Perez
Number of employees1514
Security typeOrdinary Share
Fiscal year-endMay 22
Address455 Market Street
CitySAN FRANCISCO
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code94105
Phone14156898429
Websitehttps://en-gb.hingehealth.com/
Ticker SymbolHNGE
IPO dateMay 22, 2025
Founded at2016
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data